Evaluation of heat shock protein 70 kDa in plasma of patients with active infective valve endocarditis

  • A. A. Krikunov National M. M. Amosov Institute of Cardiovascular Surgery National Academy of Medical Sciences of Ukraine
  • A. B. Koltunova National M. M. Amosov Institute of Cardiovascular Surgery National Academy of Medical Sciences of Ukraine
  • E. Y. Bespalova National M. M. Amosov Institute of Cardiovascular Surgery National Academy of Medical Sciences of Ukraine
  • A. V. Petkov National M. M. Amosov Institute of Cardiovascular Surgery National Academy of Medical Sciences of Ukraine
  • F. A. Pristavka National M. M. Amosov Institute of Cardiovascular Surgery National Academy of Medical Sciences of Ukraine
  • S. P. Spysarenko National M. M. Amosov Institute of Cardiovascular Surgery National Academy of Medical Sciences of Ukraine
  • T. A. Malysheva National M. M. Amosov Institute of Cardiovascular Surgery National Academy of Medical Sciences of Ukraine
Keywords: infective endocarditis, heat shock proteins 70 kDa, persistent inflammation, immunosuppression and catabolism syndrome

Abstract

Development of infective endocarditis initiates a complex immunological response of the organism changing in time: the prevalence of pro-and anti-inflammatory mechanisms at the beginning is replaced by immunosuppression. A significant role in antigen presentation, cross-presentation, activation of macrophages and lymphocytes play the heat shock proteins (HSP). HSP provide a link between innate and adaptive immunity. The study included 18 patients with active infective valve endocarditis operated from 01.01.2010 по 31.12.2011yy. Assessment of the relationship between clinical characteristics of patients with infective endocarditis and the initial level of heat shock protein 70 kDa was performed. Patients with the presence of signs of chronic persistent infection and catabolism were characterized by high levels of heat shock proteins 70 kDa. The presence of high levels of heat shock proteins 70 kDa indicated the depression of cellular and humoral immunity. These results confirm the development of the syndrome of persistent inflammation, immunosuppression and catabolism in patients with infective endocarditis.

References

1. Cahill T. J., Prendergast B. D. Infective endocarditis // Lancet. – 2016. –Vol. 27; 387 (10021). – P. 882–93.

2. Gentile L. F., Guenca A. G., Efron P. A., Ang D., Bihorac A., McKiney B. A., Moldawer L. L., Moore F. A. Persistent inflammation and immunosuppression: a common syndrome and new horizon for surgical intensive care // The journal of trauma and acute care surgery. – 2012. – Vol. 72 (6). – P.1491–501. Epub 2012/06/15. [PubMed:22695412]

3. Santagata S., Mendillo M. L., Tang Y. C., Subramanian A., Perley C. C., Roche S. P. et al. Tight coordination of protein translation and HSF1 activation supports the anabolic malignant state // Science. – 2013. – Vol. 341:1238303.

4. Tamura Y., Torigoe T., Kukita K., Saito K., Okuya K., Kutomi G., Hirata K. and Sato N. Heat-Shock Proteins as Endogenous Ligands Building a Bridge between Innate and Adaptive Immunity // Immunotherapy. – 2012. – Vol. 4. – P. 841–852.

5. Sun C., Li H. L., Shi M. L., Liu Q. H., Bai J. and Zheng J. N. Diverse Roles of C-Terminal Hsp70-Interacting Protein (CHIP) in Tumorigenesis // Journal of Cancer Research and Clinical Oncology. – 2014. – Vol. 140. – P. 189–197.

6. Boomer J. S., To K., Chang K. C., Takasu O., Osborne D. F., Walton A. H., Bricker T. L., Jaman S. D., Kresel D., Krupnick A. S., Srivastava A., Swanson P. E., Green J. M., Hotchkiss R. S. Immunosupression in patients who die of sepsis and multiple organ failure // JAMA. – 2011. – Vol. 306. – P. 2594–2605.

7. Williams, J. H., Ireland H. E. Sensing danger–Hsp72 and HMGB1 as candidate signals // J. Leukoc. Biol. – 2008. – Vol. 83. – P. 489–492.

8. Inoue S., Suzuki K., Komori Y., Morishita Y., Suzuki-Utsunomiya K., Hozumi K., Inokuchi S., Sato T. Persistent inflammation and T-cell exhaustion in severe sepsis eldery // Crit Care. – 2014. – Vol. 18 (3): R130.

9. Taldone T., Patel H. J., Bolaender A., Patel M. R. and Chiosis G. Protein Chaperones: A Composition of Matter Review (2008-2013) // Expert Opinion on Therapeutic Patents. – 2014. – Vol.24. – P. 501–518.
Published
2016-09-12
How to Cite
1.
Krikunov AA, Koltunova AB, Bespalova EY, Petkov AV, Pristavka FA, Spysarenko SP, Malysheva TA. Evaluation of heat shock protein 70 kDa in plasma of patients with active infective valve endocarditis. ujcvs [Internet]. 2016Sep.12 [cited 2024Dec.22];(2 (25):39-5. Available from: http://cvs.org.ua/index.php/ujcvs/article/view/229
Section
ACQUIRED HEART DISEASES